In the present study, we found four FR-DELs (LINC01152, AC004585.1, MAPT-IT1, and AC026401.3) that could be used as prognosis and diagnosis biomarkers to predict the outcome of BC. The gene discussed is HAUS3; the disease is breast cancer.